Pharmacovigilance Jobs at Piramal Life Sciences

By: Pharma Tips | Views: 2191 | Date: 28-Nov-2016

Piramal Life Sciences Limited (PLSL) is an independent research-driven drug company that was recently demerged from Piramal Healthcare Limited (Formerly known as Nicholas Piramal India Limited). PLSL was formerly the NCE R&D division of NPIL. PLSL has state-of-the-art R&D laboratories built over 200,000 square-feet of space in Mumbai, India and over 300 scientists engaged in drug discovery and development.

Pharmacovigilance Jobs at Piramal Life Sciences

Piramal Life Sciences Limited (PLSL) is an independent research-driven drug company that was recently demerged from Piramal Healthcare Limited (Formerly known as Nicholas Piramal India Limited). PLSL was formerly the NCE R&D division of NPIL. PLSL has state-of-the-art R&D laboratories built over 200,000 square-feet of space in Mumbai, India and over 300 scientists engaged in drug discovery and development.

Post : Head – Pharmacovigilance

Job Responsibilities:

Provide leadership to PV team and act as expert in anesthetic, narcotics and anti-emetics for inhalation and especially injectable products marketed in US, US, Europe and ROW region.

Expertise in handling MHRA, FDA and other regulatory PV inspections.

Provide leadership in integration of PV activity for acquired products.

Provide expertise in assessment of PV impact and activity for any prospective products.

EssentialSkills & Experience:Should have 15+ years of experience in similar field / industry. Candidates should have experience in either Pharma companies or Pharma Consulting companies.Should have sound knowledge in anesthetic, narcotics and anti-emetics for inhalation and especially injectable products marketed in US, US, Europe and ROW region.Should have handled / faced MHRA, FDA and other regulatory PV inspectionsPlanning and organizational skills – prioritization, resource allocation, multi-tasking.Proficiency in speaking, comprehending, reading and writing English and Hindi is requiredExperience in collaborating with Cross border stakeholders will be preferred